Citation

Katona CLE, Shankar KK. Rev. Clin. Gerontol. 2004; 14(4): 283-306.

Copyright

(Copyright © 2004, Cambridge University Press)

DOI

10.1017/S0959259805001632

PMID

unavailable

Abstract

[Abstract unavailable]

Language: en

Keywords

human; suicide; systematic review; prognosis; aged; dementia; aging; psychotherapy; depression; prevalence; stroke; lithium; clinical trial; risk factor; review; rating scale; doxepin; brain infarction; citalopram; clinical feature; cognitive defect; fluoxetine; imipramine; moclobemide; monoamine oxidase inhibitor; nortriptyline; paroxetine; sedation; serotonin uptake inhibitor; sertraline; tricyclic antidepressant agent; automutilation; patient care; behavior therapy; cognitive therapy; social psychology; epidemiological data; social aspect; neurotoxicity; physical disability; electroconvulsive therapy; Alzheimer disease; dosulepin; lofepramine; mianserin; psychopharmacotherapy; cardiotoxicity; drug safety; placebo; problem solving; demography; drug efficacy; meta analysis; maprotiline; symptom; maintenance therapy; biology; cerebrovascular disease; estrogen; phenelzine; anticholinergic effect; anticholinergic syndrome; heredity; nimodipine; transient ischemic attack; treatment response; unspecified side effect